Open navigation
Search

Life Sciences & Healthcare

Latest

  • How the EU Pharma Package will reshape orphan drug regulation
    28 Jul 2026 8 min read
  • The extension of the Bolar exemption in the EU Pharma Package
    21 Jul 2026 8 min read
  • Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package
    15 Jul 2026 7 min read
  • UK Clinical Trial Transparency and Patent Strategy
    13 Jul 2026 12 min read
  • T 655/24 - credibility test for improved technical effect applied to determine inventive step for a single amino acid change following G 2/21
    02 Jul 2026 11 min read
  • ICC Rules 2026: Key Reforms in Context
    09 Jun 2026 11 min read
  • EU AI Act Developments: Key Political Agreement on the Digital Omnibus on AI, Implementation Timeline and Transparency Consultation
    13 May 2026 4 min read

1 specialist practice area in Life Sciences & Healthcare

CMS Adonnino Ascoli & Cavasola Scamoni has developed a broad expertise in the field of life sciences. Our life sciences & healthcare practice includes the assistance of clients which operate in the fields of pharmaceuticals, biotechnology medical devices and more generally health care services. We regularly advise life science & healthcare companies on corporate governance matters and licensing and contracts, as well as day-to-day corporate issues.

Our team can count on professionals “borrowed” on a regular basis, to life sciences from other departments of the firm including team of corporate and intellectual property professionals who can boast a significant experience securing and defending patent positions and regulatory law issues in order for companies to comply with the Italian regulatory law.

Our specialist practice areas

Life Sciences & Healthcare Insights

How the EU Pharma Package will reshape orphan drug regulation

How the EU Pharma Package will reshape orphan drug regulation

28 Jul 2026 8 min read
CMS Expert Guide to cannabis law and legislation

CMS Expert Guide to cannabis law and legislation

23 Jul 2026 7 min read
CMS Expert Guide to advertising of medicines and medical devices

CMS Expert Guide to advertising of medicines and medical devices

22 Jul 2026 2 min read
The extension of the Bolar exemption in the EU Pharma Package

The extension of the Bolar exemption in the EU Pharma Package

21 Jul 2026 8 min read
Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package

Stability as strategy: The UK’s regulatory position in the wake of the EU Pharmaceutical Package

15 Jul 2026 7 min read
UK Clinical Trial Transparency and Patent Strategy

UK Clinical Trial Transparency and Patent Strategy

13 Jul 2026 12 min read
T 655/24 - credibility test for improved technical effect applied to determine inventive step for a single amino acid change following G 2/21

T 655/24 - credibility test for improved technical effect applied to determine inventive step for a single amino acid change following G 2/21

02 Jul 2026 11 min read
ICC Rules 2026: Key Reforms in Context

ICC Rules 2026: Key Reforms in Context

09 Jun 2026 11 min read

Events

  • Italy
    10 Sep 2026

    IP Insights webinar series 2026 - Autumn

  • Italy
    30 Sep 2026

    On the Pulse Webinar Series 2026 - Autumn

Local market knowledge. Global outlook

We provide future-facing legal advice to help your organisation thrive. Combining local market knowledge and a global perspective, and with lawyers in locations worldwide, your organisation benefits from the expertise it needs, even across borders.

About CMS
People across CMS Find a Lawyer
10,000+ Staff
7,400+ Lawyers
Locations across CMS Find an office
50+ Countries
90+ Offices
22 Member firms
Back to top Back to top
Warning: Fraudulent emails and messages
Opens in new window